GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
“Netflix should fire racist, Trump Deranged Susan Rice, IMMEDIATELY, or pay the consequences.”...
L Todd Wood talks with Fabien from the Euro Bytes team about changes on The Continent and Marco Rubio's speech at the Munich Security Conference....
The adorable 2-year-old pup abandoned by a heartless traveler at Las Vegas' Harry Reid International Airport has found a forever home with one of the cops who helped rescue him....
